Houston Methodist The Woodlands Hospital, located in The Woodlands, Texas, is one of seven community hospitals that are part of Houston Methodist. It employs more than 900 people, has an estimated 600 affiliated doctors and admits more than 2,800 patients annually.

During the past decade, Houston Methodist The Woodlands Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Houston Methodist The Woodlands Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "NRG Oncology" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist The Woodlands Hospital" #1 collaborator was "NRG Oncology" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Houston Methodist The Woodlands Hospital" are "Endometrial Endometrioid Adenocarcinoma" (2 trials), "Invasive Breast Carcinoma" (2 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials), "Ovarian Seromucinous Carcinoma" (2 trials) and "Recurrent Fallopian Tube Clear Cell Adenocarcinoma" (2 trials). Many other conditions were trialed in "Houston Methodist The Woodlands Hospital" in a lesser frequency.

Most popular intervention types in "Houston Methodist The Woodlands Hospital" are "Drug" (13 trials), "Other" (13 trials), "Biological" (9 trials), "Procedure" (8 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Biospecimen Collection" (6 trials), "Computed Tomography" (6 trials), "Pembrolizumab" (6 trials) and "Questionnaire Administration" (6 trials). Other intervention names were less common.

The vast majority of trials in "Houston Methodist The Woodlands Hospital" are 10 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Houston Methodist The Woodlands Hospital". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Houston Methodist The Woodlands Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Houston Methodist The Woodlands Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".